Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AML patients lacking KIR ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants
    Meeting Abstract

    Hsu, K. C.; Taylor, C. A.; O'Reilly, R. J.; Horowitz, M. M.; Arkun, K.; Pinto, C.; Dupont, B.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Position and copy number dependence of the central polypurine tract (cPPT) function in simple and complex lentiviral vectors
    Meeting Abstract

    Chang, A. H.; Lisowski, L.; Stephan, M.; Riviere, I.; Sadelain, M.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Analysis of the genomic stability of herpes simplex virus thymidine kinase variants in retrovirally transduced lymphocytes
    Meeting Abstract

    Capacio, V. L.; Fan, Y.; Stefanski, J.; Chang, A. H.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Globin gene transfer as a potential treatment for the β-thalassaemias and sickle cell disease
    Journal Article

    Sadelain, M.
    Vox Sanguinis (2004)

    Fulltext@MSK | Save
  • The ABCs of artificial antigen presentation
    Journal Article

    Kim, J.; Latouche, J. B.; Riviere, I.; Sadelain, M.
    Nature Biotechnology (2004)

    Fulltext@MSK | Save
  • Clinical research in the United States at a crossroads: Proposal for a novel public-private partnership to establish a national clinical research enterprise
    Journal Article

    Crowley, W. F. Jr; Sherwood, L.; Salber, P.; Scheinberg, D.; Slavkin, H.; Tilson, H.; Reece, E. A.; Catanese, V.; Johnson, S. B.; Dobs, A.; more...
    JAMA - Journal of the American Medical Association (2004)

    Fulltext@MSK | Save
  • Novel strategies for cancer therapy: the potential of genetically modified T lymphocytes
    Journal Article

    Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Current Hematology Reports (2004)

    Fulltext@MSK | Save
  • Globin gene transfer for treatment of the β-thalassemias and sickle cell disease
    Journal Article

    Sadelain, M.; Rivella, S.; Lisowski, L.; Samakoglu, S.; Riviere, I.
    Best Practice and Research: Clinical Haematology (2004)

    Fulltext@MSK | Save